Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Hoentjen

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Digestive Diseases and Sciences|January 8, 2026
Extending Knowledge: The Case for Treat-to-Target Management in Patients with Ulcerative Colitis Who Fail Early TreatmentLisa M A van Lierop, Frank Hoentjen
Inflammatory Bowel Diseases|June 12, 2014
Cuff and pouch cancer in patients with inflammatory bowel disease: what surveillance strategy should be recommended?Lauranne A A P Derikx, Frank Hoentjen
Nederlands Tijdschrift Voor Geneeskunde|August 13, 2011
[Ileus as a manifestation of intestinal tuberculosis]Frank Hoentjen, Pieter C Stokkers, Jan Veenstra
Journal of Crohn'S & Colitis|February 20, 2020
Type C Mucosa in Pouch Surveillance: How Real is the Risk?Maarten Te Groen, Frank Hoentjen, Lauranne Derikx
Clinical and Experimental Gastroenterology|March 21, 2014
Golimumab for the treatment of ulcerative colitisMark Löwenberg, Nanne Kh de Boer, Frank Hoentjen
Gastroenterology|May 21, 2020
Noninferiority or Nonsuperiority?Maarten Te Groen, Nathan den Broeder, Frank Hoentjen
Clinical and Experimental Gastroenterology|April 22, 2014
Management of Crohn's disease in poor responders to adalimumabNanne Kh de Boer, Mark Löwenberg, Frank Hoentjen
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 4, 2012
Complications of peristomal recurrence of Crohn's disease: a case report and a review of literatureFrank Hoentjen, Janice C Colwell, Stephen B Hanauer
The New England Journal of Medicine|December 26, 2019
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative ColitisVince B C Biemans, Frank Hoentjen, Marieke J Pierik
Alimentary Pharmacology & Therapeutics|October 5, 2020
Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' replyVince B C Biemans, Frank Hoentjen, Marieke J Pierik
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Digestive Diseases and Sciences|January 8, 2026
Extending Knowledge: The Case for Treat-to-Target Management in Patients with Ulcerative Colitis Who Fail Early TreatmentLisa M A van Lierop, Frank Hoentjen
Inflammatory Bowel Diseases|June 12, 2014
Cuff and pouch cancer in patients with inflammatory bowel disease: what surveillance strategy should be recommended?Lauranne A A P Derikx, Frank Hoentjen
Nederlands Tijdschrift Voor Geneeskunde|August 13, 2011
[Ileus as a manifestation of intestinal tuberculosis]Frank Hoentjen, Pieter C Stokkers, Jan Veenstra
Journal of Crohn'S & Colitis|February 20, 2020
Type C Mucosa in Pouch Surveillance: How Real is the Risk?Maarten Te Groen, Frank Hoentjen, Lauranne Derikx
Clinical and Experimental Gastroenterology|March 21, 2014
Golimumab for the treatment of ulcerative colitisMark Löwenberg, Nanne Kh de Boer, Frank Hoentjen
Gastroenterology|May 21, 2020
Noninferiority or Nonsuperiority?Maarten Te Groen, Nathan den Broeder, Frank Hoentjen
Clinical and Experimental Gastroenterology|April 22, 2014
Management of Crohn's disease in poor responders to adalimumabNanne Kh de Boer, Mark Löwenberg, Frank Hoentjen
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 4, 2012
Complications of peristomal recurrence of Crohn's disease: a case report and a review of literatureFrank Hoentjen, Janice C Colwell, Stephen B Hanauer
The New England Journal of Medicine|December 26, 2019
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative ColitisVince B C Biemans, Frank Hoentjen, Marieke J Pierik
Alimentary Pharmacology & Therapeutics|October 5, 2020
Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' replyVince B C Biemans, Frank Hoentjen, Marieke J Pierik
Pageof 19